ESSA Pharma Inc. (EPIX)
USD 1.61
(-1.83%)
USD 1.61
(-1.83%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -19.78 Million | -28.7 Million | -25.41 Million | -16.98 Million | -12.24 Million | -10.21 Million |
| Net Income | -26.58 Million | -35.1 Million | -36.8 Million | -23.44 Million | -10.44 Million | -11.62 Million |
| Depreciation & Amortization | 118.49 Thousand | 121.78 Thousand | 109.46 Thousand | 110.32 Thousand | 18.29 Thousand | 34.48 Thousand |
| Deferred income taxes | -671.79 Thousand | - | -107.02 Thousand | -156.08 Thousand | 14.98 Thousand | -47.7 Thousand |
| Stock-based compensation | 5007.47 | 7888.09 | 9476.11 | 7522.61 | 1146.71 | 1.4 Million |
| Change in working capital | 2.33 Million | -780 Thousand | 1.94 Million | -1.23 Million | -1.25 Million | -659.55 Thousand |
| Other non-cash items | 7316.00 | -830.78 Thousand | -35.29 Thousand | 224.07 Thousand | -1.73 Million | 682.75 Thousand |
| Investing Cash Flow | -3.52 Million | -52.34 Million | -35.01 Million | -21.73 Million | -45.5 Thousand | -201.39 Thousand |
| Investments in PPE | -4.00 | - | - | - | - | - |
| Acquisitions | - | - | - | - | -246.9 Thousand | - |
| Investment purchases | -365.2 Million | -296.01 Million | -57.02 Million | -22.01 Million | - | - |
| Sales/Maturities of investments | 361.67 Million | 242.95 Million | 22.01 Million | - | - | - |
| Other Investing Activities | -3527.15 | 705.02 Thousand | -35.01 Thousand | 274.08 Thousand | 201.39 Thousand | -201.39 Thousand |
| Financing Cash Flow | -68.15 Thousand | 252.73 Thousand | 141.99 Million | 41.77 Million | 50.81 Million | 21.31 Million |
| Debt repayment | -136.86 Thousand | -134.02 Thousand | -100.28 Thousand | -4 Million | -2.8 Million | -1.99 Million |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 68.7 Thousand | 386.75 Thousand | 149.99 Million | 48.99 Million | 36 Million | 26.04 Million |
| Other Financing Activities | 68.71 | 252.73 | -7.9 Million | -3.2 Million | 17.61 Million | -2.73 Million |
| Accounts receivables | -128.84 Thousand | 482.8 Thousand | -157.57 Thousand | 89.93 Thousand | -59.66 Thousand | -35.87 Thousand |
| Accounts payables | - | - | 2.66 Million | -46.35 Thousand | -1.01 Million | -1.12 Million |
| Inventory | - | - | 157.57 Thousand | -89.93 Thousand | 59.66 Thousand | - |
| Other working capital | 2.46 Million | -1.26 Million | -721.14 Thousand | -1.19 Million | -243.8 Thousand | 461.27 Thousand |
| Cash at beginning of period | 57.07 Million | 137.82 Million | 56.32 Million | 53.32 Million | 14.82 Million | 3.95 Million |
| Cash at end of period | 33.7 Million | 57.07 Million | 137.82 Million | 56.32 Million | 53.32 Million | 14.82 Million |
| Capital Expenditure | -4.00 | - | - | - | - | - |
| Effect of forex changes on cash | 2459.00 | 51.27 Thousand | -56.11 Thousand | -58.18 Thousand | -21.8 Thousand | -19.09 Thousand |
| Net cash flow / Change in cash | -23.37 Million | -80.74 Million | 81.5 Million | 2.99 Million | 38.49 Million | 10.87 Million |
| Free Cash Flow | -19.78 Million | -28.7 Million | -25.41 Million | -16.98 Million | -12.24 Million | -10.21 Million |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -7.23 Million | -8.98 Million | -5.96 Million | -5.48 Million | -26.58 Million | -7.29 Million |
| Depreciation & Amortization | 22.66 Thousand | 15.5 Thousand | 23 Thousand | 27.15 Thousand | 118.49 Thousand | 30.44 Thousand |
| Deferred income taxes | - | - | -204.07 Thousand | -188.29 Thousand | -671.79 Thousand | -204.21 Thousand |
| Stock-based compensation | 2.6 Million | 1.13 Million | 803.41 Thousand | 845.69 Thousand | 5007.47 | 1.16 Million |
| Change in working capital | -613.63 Thousand | 946.18 Thousand | -1.03 Million | 225.53 Thousand | 2.33 Million | 1.52 Million |
| Other non-cash items | 2.28 Million | 1.2 Million | -408.33 Thousand | 82.84 Thousand | 7316.00 | 1.46 Million |
| Investing Cash Flow | -803.36 Thousand | 62.86 Million | 8.23 Million | -264.64 Thousand | -3.52 Million | -2.47 Million |
| Investments in PPE | -4.96 | - | - | - | - | - |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | -5.17 Million | 38.58 Million | -60.98 Million | -106.89 Million | -365.2 Million | -79.99 Million |
| Sales/Maturities of investments | 4.37 Million | 24.27 Million | 69.22 Million | 106.63 Million | 361.67 Million | 77.52 Million |
| Other Investing Activities | 23.48 Thousand | 62.5 Million | 8232.51 | -264.65 | -3527.15 | -2472.43 |
| Financing Cash Flow | 15.58 Thousand | 647.81 Thousand | 196.65 Thousand | -13.64 Thousand | -68.15 Thousand | -35.52 Thousand |
| Debt repayment | - | - | - | -32.06 Thousand | -136.86 Thousand | -35.52 Thousand |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 15.58 Thousand | 647.81 Thousand | 196.65 Thousand | 18.56 Thousand | 68.7 Thousand | 136.35 |
| Other Financing Activities | 25.57 Thousand | 643.6 Thousand | 196.66 | -145.00 | 68.71 | -136.35 |
| Accounts receivables | 32.3 Thousand | -34.95 Thousand | -45.55 Thousand | -1885.92 | -128.84 Thousand | -125.08 Thousand |
| Accounts payables | - | - | - | - | - | - |
| Inventory | - | - | - | - | - | - |
| Other working capital | -645.94 Thousand | 981.14 Thousand | -991.14 Thousand | 227.41 Thousand | 2.46 Million | 1.64 Million |
| Cash at beginning of period | 91.68 Million | 35.34 Million | 33.7 Million | 38.46 Million | 57.07 Million | 44.3 Million |
| Cash at end of period | 85.98 Million | 91.68 Million | 35.34 Million | 33.7 Million | 33.7 Million | 38.46 Million |
| Capital Expenditure | -4.96 | - | - | - | - | - |
| Effect of forex changes on cash | -1899.00 | 4083.00 | 438.00 | 1635.00 | 2459.00 | -1372.00 |
| Net cash flow / Change in cash | -5.69 Million | 56.33 Million | 1.64 Million | -4.76 Million | -23.37 Million | -5.83 Million |
| Free Cash Flow | -5.54 Million | -6.88 Million | -6.78 Million | -4.48 Million | -19.78 Million | -3.32 Million |
0RGI
4551
3035
G13
7570
WGLIF